|
| CDK6 and p16INK4a in lymphoid malignancies |
|
https://doi.org/10.18632/oncotarget.1541
Karoline Kollmann, and Veronika Sexl
|
| 1858-1859 |
|
| Targeting IL11 signaling in colon cancer |
|
https://doi.org/10.18632/oncotarget.1410
Matthias Ernst, and Tracy L. Putoczki
|
| 1860-1861 |
|
| Hexokinase 2 as oncotarget |
|
https://doi.org/10.18632/oncotarget.1563
Krushna C. Patra, and Nissim Hay
|
| 1862-1863 |
|
| p16 in HPVassociated cancers |
|
https://doi.org/10.18632/oncotarget.1523
Karl Munger, Tyshia K. Gwin, and Margaret E. McLaughlin-Drubin
|
| 1864-1865 |
|
| Mouse models and antiHER2 therapies |
|
https://doi.org/10.18632/oncotarget.1481
Ariella B. Hanker, Rebecca S. Cook, and Carlos L. Arteaga
|
| 1866-1867 |
|
| Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges |
|
https://doi.org/10.18632/oncotarget.1537
Biao Liu, Carl D. Morrison, Candace S. Johnson, Donald L. Trump, Maochun Qin, Jeffrey C. Conroy, Jianmin Wang, and Song Liu
|
| 1868-1881 |
|
| Increased expression and copy number amplification of LINE1 and SINE B1 retrotransposable elements in murine mammary carcinoma progression |
|
https://doi.org/10.18632/oncotarget.1188
Alberto Gualtieri, Federica Andreola, Ilaria Sciamanna, Paola Sinibaldi Vallebona, Annalucia Serafino, and Corrado Spadafora
|
| 1882-1893 |
|
| TAp63 regulates oncogenic miR155 to mediate migration and tumour growth |
|
https://doi.org/10.18632/oncotarget.1228
Sam Mattiske, Kristen Ho, Jacqueline E. Noll, Paul M. Neilsen, David F. Callen, and Rachel J. Suetani
|
| 1894-1903 |
|
| Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis |
|
https://doi.org/10.18632/oncotarget.1264
Daniela Loetsch, Elisabeth Steiner, Klaus Holzmann, Sabine Spiegl-Kreinecker, Christine Pirker, Juraj Hlavaty, Helga Petznek, Balazs Hegedus, Tamas Garay, Thomas Mohr, Wolfgang Sommergruber, Walter Berger, and Michael Grusch
|
| 1904-1918 |
|
| Identification of novel tumor suppressor proteases by degradome profiling of colorectal carcinomas |
|
https://doi.org/10.18632/oncotarget.1303
Julia M. Fraile, Gonzalo R. Ordoñez, Pedro M. Quiros, Aurora Astudillo, Jose A. Galvan, Dolors Colomer, Carlos Lopez-Otin, Jose M.P. Freije, and Xose S. Puente
|
| 1919-1932 |
|
| HoxA9 regulated Bcl2 expression mediates survival of myeloid progenitors and the severity of HoxA9dependent leukemia |
|
https://doi.org/10.18632/oncotarget.1306
Gabriela Brumatti, Marika Salmanidis, Chung H Kok, Rebecca A Bilardi, Jarrod J Sandow, Natasha Silke, Kylie Manson, Jolanda Visser, Anissa M Jabbour, Stefan P Glaser, Toru Okamoto, Philippe Bouillet, Richard J D'Andrea, and Paul G Ekert
|
| 1933-1947 |
|
| Selective targeting of human colon cancer stemlike cells by the mTOR inhibitor Torin1 |
|
https://doi.org/10.18632/oncotarget.1310
Maria Giovanna Francipane, and Eric Lagasse
|
| 1948-1962 |
|
| Mode of cell death induced by the HSP90 inhibitor 17AAG tanespimycin is dependent on the expression of proapoptotic BAX |
|
https://doi.org/10.18632/oncotarget.1419
Marissa V Powers, Melanie Valenti, Susana Mirander, Alison Maloney, Suzanne A Eccles, George Thomas, Paul A Clarke, and Paul Workman
|
| 1963-1975 |
|
| p53 regulates the transcription of the antiinflammatory molecule developmental endothelial locus1 Del1 |
|
https://doi.org/10.18632/oncotarget.1318
Hyesoon Kim, Seung-Hwan Lee, Mi-Ni Lee, Goo Taeg Oh, Kyung-Chul Choi, and Eun Young Choi
|
| 1976-1985 |
|
| Mitochondrial oxidative stress is the achille’s heel of melanoma cells resistant to Brafmutant inhibitor |
|
https://doi.org/10.18632/oncotarget.1420
Paola Corazao-Rozas, Pierre Guerreschi, Manel Jendoubi, Fanny André, Aurélie Jonneaux, Camille Scalbert, Guillaume Garçon, Myriam Mallet-Martino, Stéphane Balayssac, Stephane Rocchi, Ariel Savina, Pierre Formstecher, Laurent Mortier, Jerome Kluza, and Philippe Marchetti
|
| 1986-1998 |
|
| Chemoresistance to gemcitabine in hepatoma cells induces epithelialmesenchymal transition and involves activation of PDGFD pathway |
|
https://doi.org/10.18632/oncotarget.1471
Qiong Wu, Rui Wang, Qingling Yang, Xin Hou, Sulian Chen, Yueyue Hou, Changjie Chen, Yan Yang, Lucio Miele, Fazlul Sarkar, Yuqing Chen, and Zhiwei Wang
|
| 1999-2009 |
|
| NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals |
|
https://doi.org/10.18632/oncotarget.1451
Sabine Becker-Weimann, Gaofeng Xiong, Saori Furuta, Ju Han, Irene Kuhn, Uri-David Akavia, Dana Pe'er, Mina J. Bissell, and Ren Xu
|
| 2010-2020 |
|
| FOXD3 is a novel tumor suppressor that affects growth invasion metastasis and angiogenesis of neuroblastoma |
|
https://doi.org/10.18632/oncotarget.1579
Dan Li, Hong Mei, Meng Qi, Dehua Yang, Xiang Zhao, Xuan Xiang, Jiarui Pu, Kai Huang, Liduan Zheng, and Qiangsong Tong
|
| 2021-2044 |
|
| 1433σ attenuates RhoGDI2induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells |
|
https://doi.org/10.18632/oncotarget.1334
In-Kyu Kim, Sun-Mi Park, Hee Jun Cho, Kyoung Eun Baek, In-Koo Nam, Seung-Ho Park, Ki-Jun Ryu, Jinhyun Ryu, Jungil Choi, Soon-Chan Hong, Jae Won Kim, Chang Won Lee, Sang Soo Kang, and Jiyun Yoo
|
| 2045-2056 |
|
| Induction and transport of Wnt 5a during macrophageinduced malignant invasion is mediated by two types of extracellular vesicles |
|
https://doi.org/10.18632/oncotarget.1336
Kerstin Menck, Florian Klemm, Julia Christina Gross, Tobias Pukrop, Dirk Wenzel, and Claudia Binder
|
| 2057-2066 |
|
| Alterations of immune response of nonsmall cell lung cancer with Azacytidine |
|
https://doi.org/10.18632/oncotarget.1542
John Wrangle, Wei Wang, Alexander Koch, Hariharan Easwaran, Helai P. Mohammad, Xiaoyu Pan, Frank Vendetti, Wim VanCriekinge, Tim DeMeyer, Zhengzong Du, Princy Parsana, Kristen Rodgers, Ray-Whay Yen, Cynthia A. Zahnow, Janis M. Taube, Julie R. Brahmer, Scott S. Tykodi, Keith Easton, Richard D. Carvajal, Peter A. Jones, Peter W. Laird, Daniel J. Weisenberger, Salina Tsai, Rosalyn A. Juergens, Suzanne L. Topalian, Charles M. Rudin, Malcolm V. Brock, Drew Pardoll, and Stephen B. Baylin
|
| 2067-2079 |
|
| BET bromodomain protein inhibition is a therapeutic option for medulloblastoma |
|
https://doi.org/10.18632/oncotarget.1534
Anton George Henssen, Theresa Thor, Andrea Odersky, Lukas Heukamp, Nicolai El-Hindy, Anneleen Beckers, Frank Slpeleman, Kristina Althoff, Simon Schäfers, Alexander Schramm, Ulrich Sure, Gudrun Fleischhack, Angelika Eggert, and Johannes Hubertus Schulte
|
| 2080-2095 |
|
| ICRAC controls the rapid androgen response in human primary prostate epithelial cells and is altered in prostate cancer |
|
https://doi.org/10.18632/oncotarget.1483
Christian Holzmann, Tatiana Kilch, Sven Kappel, Andrea Armbrüster, Volker Jung, Michael Stöckle, Ivan Bogeski, Eva C Schwarz, and Christine Peinelt
|
| 2096-2107 |
|
| Bone marrow adipocytes promote tumor growth in bone via FABP4dependent mechanisms |
|
https://doi.org/10.18632/oncotarget.1482
Mackenzie Herroon, Erandi Rajagurubandara, Aimalie L Hardaway, Katelyn Powell, Audrey Turchick, Daniel Feldmann, and Izabela Podgorski
|
| 2108-2123 |
|
| 6p223 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer |
|
https://doi.org/10.18632/oncotarget.1485
He Shen, Carl D. Morrison, Jianmin Zhang, Willie Underwood III, Nuo Yang, Costa Frangou, Kevin Eng, Karen Head, Roni J. Bollag, Sravan K. Kavuri, Amyn M. Rojiani, Yingwei Li, Li Yan, Annette Hill, Anna Woloszynska-Read, Jianmin Wang, Song Liu, Donald L. Trump, and Candace S. Johnson
|
| 2124-2134 |
|
| Aberrant chimeric RNA GOLM1MAK10 encoding a secreted fusion protein as a molecular signature for human esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.1465
Hao Zhang, Wan Lin, Kalpana Kannan, Liming Luo, Jing Li, Pei-Wen Chao, Yan Wang, Yu-Ping Chen, Jiang Gu, and Laising Yen
|
| 2135-2143 |
|
| KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation |
|
https://doi.org/10.18632/oncotarget.1555
Changcun Guo, Lee H. Chen, Yafen Huang, Chun-Chi Chang, Ping Wang, Christopher J. Pirozzi, Xiaoxia Qin, Xuhui Bao, Paula K. Greer, Roger E. McLendon, Hai Yan, Stephen T. Keir, Darell D. Bigner, and Yiping He
|
| 2144-2153 |
|
| Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase9 through TBP and promotes invasion in Nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.1367
Hsin-Pai Li, Chen-Ching Peng, I-Che Chung, Mei-Yuan Huang, Shao-Tung Huang, Chia-Chun Chen, Kai-Ping Chang, Cheng-Lung Hsu, and Yu-Sun Chang
|
| 2154-2165 |
